Becton Dickinson & Co
BDXNYSECIK 10795HealthcareFiscal year ends Sep 30
Reports and events: 343 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:36 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000010795-26-000035 |
| 2026-08-0606:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053790 |
| 2026-07-2206:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-049103 |
| 2026-05-2908:39 ET | 8-K | 7.01 Regulation FD disclosure | 0001628280-26-039005 |
| 2026-05-2017:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-26-022270 |
| 2026-05-1216:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-020828 |
| 2026-05-0716:34 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000010795-26-000026 |
| 2026-05-0706:33 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-031642 |
| 2026-05-0706:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031638 |
| 2026-04-2916:16 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000010795-26-000012 |
| 2026-04-0916:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-024472 |
| 2026-04-0216:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-023185 |
| 2026-02-2516:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006794 |
| 2026-02-1016:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-004601 |
| 2026-02-0916:19 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0000010795-26-000005 |
| 2026-02-0916:18 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-042827 |
| 2026-02-0906:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-006182 |
| 2026-02-0516:21 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-039448 |
| 2026-02-0516:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-005793 |
| 2026-01-3016:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-004393 |
| 2026-01-0616:45 ET | 8-K | 5.04 Item not in the standard list | 0001193125-26-004659 |
| 2025-12-1811:25 ET | DEF 14A | Proxy statementPeriod 2025-12-12 | 0001628280-25-057846 |
| 2025-12-0116:18 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-054447 |
| 2025-11-2516:27 ET | 10-K | Annual reportPeriod 2025-09-30 | 0000010795-25-000099 |
| 2025-11-1716:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-25-052625 |
| 2025-11-0606:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049835 |
| 2025-10-1516:18 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-045106 |
| 2025-09-1820:46 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-25-035307 |
| 2025-08-0716:26 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000010795-25-000072 |
| 2025-08-0706:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-25-000069 |
| 2025-07-1417:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-158797 |
| 2025-07-1406:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-158404 |
| 2025-06-1616:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-25-000049 |
| 2025-05-0216:34 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000010795-25-000041 |
| 2025-05-0116:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000010795-25-000039 |
| 2025-05-0106:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-25-000036 |
| 2025-03-2716:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000010795-25-000025 |
| 2025-02-0617:03 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0000010795-25-000022 |
| 2025-02-0516:32 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-25-000019 |
| 2025-01-3116:06 ET | 8-K | 5.07 Shareholder vote results | 0000010795-25-000011 |
| 2025-01-1006:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-25-000005 |
| 2024-12-1910:36 ET | DEF 14A | Proxy statementPeriod 2024-12-16 | 0000010795-24-000096 |
| 2024-11-2713:36 ET | 10-K | Annual reportPeriod 2024-09-30 | 0000010795-24-000084 |
| 2024-11-0706:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-24-000078 |
| 2024-10-0217:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-24-000071 |
| 2024-08-3016:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950103-24-012970 |
| 2024-08-0116:33 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000010795-24-000067 |
| 2024-08-0106:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-24-000064 |
| 2024-07-1206:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-032969 |
| 2024-06-0717:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-24-029309 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 14:28 ET. Listed shows no prices and gives no investment advice.